(Q35692616)

9 August 2017

1 reference

title

Nonmyeloablative allogeneic stem cell transplantation using alternative donors (English)

1 reference

9 August 2017

Timothy F Goggins

1

1 reference

9 August 2017

David R Rizzieri

series ordinal

2

1 reference

9 August 2017

publication date

1 March 2004

1 reference

9 August 2017

1 reference

9 August 2017

volume

11

1 reference

9 August 2017

issue

2

1 reference

9 August 2017

page(s)

86-96

1 reference

Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow Grafts

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100215

Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin-based reduced-intensity preparative regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100215

Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100215

Low-intensity conditioning is sufficient to ensure engraftment in matched unrelated bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100215

Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induc

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100215

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100215

Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100215

Allogeneic bone marrow transplantation for chronic myeloid leukemia using sibling and volunteer unrelated donors. A comparison of complications in the first 2 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100215

Hemopoietic stem cell transplantation using mouse bone marrow and spleen cells fractionated by lectins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100215

Tolerance to histocompatibility determinants in tetraparental bone marrow chimeras

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100215

Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100215

Marrow transplantation from related donors other than HLA-identical siblings

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100215

Genetically haploidentical stem cell transplantation for acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100215

Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100215

Tolerance induction by 'megadose' transplants of CD34+ stem cells: a new option for leukemia patients without an HLA-matched donor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100215

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100215

Tolerance induction by "megadose" hematopoietic transplants: donor-type human CD34 stem cells induce potent specific reduction of host anti-donor cytotoxic T lymphocyte precursors in mixed lymphocyte culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100215

Anti-Thy 1.2 monoclonal antibody linked to ricin is a potent cell-type-specific toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100215

Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100215

Umbilical cord blood transplantation: current state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100215

Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100215

Antigen-specific immune function after hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480401100215

10.1177/107327480401100215

21 January 2018

Identifiers

DOI

0 references

1 reference